Highline Wealth Partners »

An2 Therapeutics shares owned by Highline Wealth Partners

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Highline Wealth Partners from 13F filings

Historical chart of Highline Wealth Partners investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Highline Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Highline Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.4k 5.0k 1.27
2025-06-30 $5.3k 5.0k 1.06

More positions owned by Highline Wealth Partners

Nvidia Corporation Stock (NVDA)
JPMorgan Ultra-Short Income ETF Etf (JPST)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard S&P 500 ETF Etf (VOO)
Microsoft Corp Stock (MSFT)
Apple Inc Com/Inv Stock (AAPL)
iShares Core MSCI EAFE ETF Etf (IEFA)
Invesco Nasdaq 100 Etf Etf (QQQM)
Schwab Fundamental U.s. Large Company Etf Etf (FNDX)
Meta Platforms Inc Cl A Stock (META)
Vanguard Russell 1000 Value ETF Etf (VONV)
Amazon Stock (AMZN)
Tesla Stock (TSLA)
Costco Whsl Corp/N Stock (COST)
iShares 5-10 Year Investment Grade Corporate Bond ETF Etf (IGIB)

View all positions for Highline Wealth Partners

Top funds holding An2 Therapeutics

Almitas Capital
Vanguard Group
Pfizer
Peapod Lane Capital
Stonepine Capital Management
Bank of Nova Scotia
Landscape Capital Management
Bank Of Montreal
Renaissance Technologies
BlackRock
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Morgan Stanley
State Street Corporation

View all funds holding An2 Therapeutics